BridgeMD
Tests treatment safety and results for Anterior Cruciate Ligament Rupture
Official title Assessing the Efficacy of a Preoperative Navigation System in Anterior Cruciate Ligament Reconstruction
ClinicalTrials.gov ID: NCT06858930
What this study is testing
- What it's testing
- The ACL surgery robot features a preoperative navigation system that enhances the precision of bone tunnel placement. As the first dual-bundle reconstruction surgical robot developed in China, it integrates advanced technology to ensure accurate anatomical alignment.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Preoperatively, the participant or guardian is willing and able to sign the informed consent form;
- Patients aged 18 to 80 years (inclusive of 18 and 80 years), regardless of gender;
- Patients who meet the diagnostic criteria for anterior cruciate ligament (ACL) tear and have no contraindications for implantation;
- Patients with mature skeletons;
- Good compliance and willingness and ability to participate in follow-up observations as required.
You likely can't join if
- (1) Participants who have previously participated in other clinical studies of drugs, biological agents, or medical devices but did not meet the...
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, Beijing Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, Beijing Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.